A growing body of neuroscience research is converging on a counterintuitive idea: the disorderly brain activity triggered by LSD might actually work against the hyper-synchronized neural firing that ...

The Beckley Foundation and its founder and long-time psychedelics researcher Amanda Feilding announced a new research program involving a pioneering study with King's College London and UCL on the ...

Two recent studies conducted by scientists at the University Health Network and the University of Toronto provide new ...

LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...

The Beckley Foundation and its founder Amanda Feilding announced a new research program with King's College London and UCL on the effects of full dose LSD as well as a breakthrough study with the ...

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy status to an LSD formula to treat generalized anxiety disorder after an initial study has shown that a single dose of the ...

A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

A series of three new research projects announced this week will seek to illuminate our understanding of microdosing LSD. The research is being spearheaded by The Beckley Foundation and its founder, ...

A New York-based biotech firm has begun a clinical trial to study LSD as a treatment for anxiety, announcing last week that it had administered the psychedelic drug to a patient enrolled in the study ...